X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Elder Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ELDER PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ELDER PHARMA SUVEN LIFE/
ELDER PHARMA
 
P/E (TTM) x 19.2 -0.2 - View Chart
P/BV x 3.6 0.1 3,521.1% View Chart
Dividend Yield % 1.1 0.0 -  

Financials

 SUVEN LIFE   ELDER PHARMA
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
ELDER PHARMA
Jun-14
SUVEN LIFE/
ELDER PHARMA
5-Yr Chart
Click to enlarge
High Rs339380 89.1%   
Low Rs144188 76.8%   
Sales per share (Unadj.) Rs39.2491.2 8.0%  
Earnings per share (Unadj.) Rs7.5-3.2 -234.5%  
Cash flow per share (Unadj.) Rs8.814.4 60.9%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.0376.5 13.0%  
Shares outstanding (eoy) m127.2820.54 619.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.20.6 1,064.1%   
Avg P/E ratio x32.4-89.3 -36.3%  
P/CF ratio (eoy) x27.519.7 139.6%  
Price / Book Value ratio x4.90.8 653.3%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,7325,833 526.8%   
No. of employees `0001.0NA-   
Total wages/salary Rs m4162,179 19.1%   
Avg. sales/employee Rs Th5,236.1NM-  
Avg. wages/employee Rs Th436.5NM-  
Avg. net profit/employee Rs Th995.5NM-  
INCOME DATA
Net Sales Rs m4,99510,089 49.5%  
Other income Rs m194257 75.4%   
Total revenues Rs m5,18910,346 50.2%   
Gross profit Rs m1,233-792 -155.7%  
Depreciation Rs m167361 46.3%   
Interest Rs m542,756 2.0%   
Profit before tax Rs m1,205-3,653 -33.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m03,713 0.0%   
Tax Rs m255125 203.8%   
Profit after tax Rs m950-65 -1,453.3%  
Gross profit margin %24.7-7.8 -314.4%  
Effective tax rate %21.2-3.4 -617.8%   
Net profit margin %19.0-0.6 -2,935.2%  
BALANCE SHEET DATA
Current assets Rs m4,9869,240 54.0%   
Current liabilities Rs m1,0429,998 10.4%   
Net working cap to sales %79.0-7.5 -1,051.3%  
Current ratio x4.80.9 517.6%  
Inventory Days Days6146 131.7%  
Debtors Days Days3960 65.3%  
Net fixed assets Rs m3,12610,124 30.9%   
Share capital Rs m127206 61.9%   
"Free" reserves Rs m3,7175,582 66.6%   
Net worth Rs m6,2367,734 80.6%   
Long term debt Rs m4324,889 8.8%   
Total assets Rs m8,07922,882 35.3%  
Interest coverage x23.2-0.3 -7,140.4%   
Debt to equity ratio x0.10.6 11.0%  
Sales to assets ratio x0.60.4 140.2%   
Return on assets %12.411.8 105.7%  
Return on equity %15.2-0.8 -1,802.1%  
Return on capital %18.922.3 84.6%  
Exports to sales %87.53.0 2,879.1%   
Imports to sales %12.20.4 2,862.4%   
Exports (fob) Rs m4,371307 1,425.5%   
Imports (cif) Rs m61143 1,417.2%   
Fx inflow Rs m4,666307 1,522.0%   
Fx outflow Rs m942125 751.9%   
Net fx Rs m3,724181 2,054.2%   
CASH FLOW
From Operations Rs m92211,754 7.8%  
From Investments Rs m-619-561 110.5%  
From Financial Activity Rs m-698-6,762 10.3%  
Net Cashflow Rs m-3964,432 -8.9%  

Share Holding

Indian Promoters % 63.4 39.6 160.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 7.5 -  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 36.1 101.1%  
Shareholders   37,287 16,479 226.3%  
Pledged promoter(s) holding % 0.0 77.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   WOCKHARDT LTD.  J.B.CHEMICALS  MERCK LTD  BIOCON LTD  FULFORD INDIA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 23, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS